JGC
KANG

J. Goldman & Co’s iKang Healthcare Group, Inc. KANG Stock Holding History

J. Goldman & Co’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-201,500
Closed -$3.27M – 368
2015
Q1 		$3.27M Buy
+201,500
New +$3.36M 0.2% 138

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $199M AUM 30.59% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

J. Goldman & Co's KANG Position: Q2 2016 in Review

J. Goldman & Co sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2016, closing a stake of 190,300 shares — an estimated $4.16M sold.

J. Goldman & Co first reported a position in KANG in Q2 2014 and held it in 6 quarters. The position peaked at $7.43M in Q2 2015. 66 funds tracked by Wall St. Rank hold KANG as of Q2 2016.

  • J. Goldman & Co reported no remaining iKang Healthcare Group, Inc. position as of Q2 2016 after selling out during the quarter.
  • J. Goldman & Co sold 190,300 iKang Healthcare Group, Inc. shares in Q2 2016, an estimated $4.16M.
  • J. Goldman & Co first reported a position in iKang Healthcare Group, Inc. in Q2 2014 and held it in 6 quarters.
  • J. Goldman & Co's iKang Healthcare Group, Inc. position peaked at $7.43M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2016.

Based on J. Goldman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.